Report Store Get Proposal

Year-End Sale is Live! Find Exclusive Prices on the Best Selling Pharma & MedTech Reports. Check Now!

Home Blog Pharmaceutical 88

Pharmaceutical

recent-pharma-biotech-news-updates-for-astrazeneca-uniqure-csl

Notizia - Recent Pharma, Healthcare and Biotech Happenings

AstraZeneca’s COVID-19 vaccine; Type 1 diabetes research updates; FDA nod to Zebra’s X-ray modelling AI; UniQure/CSL haemophilia B gene therapy curbs bleeding in phase 3

AstraZeneca’s COVID-19 vaccine data suggest single-dose efficacy The full data from late-phase trials of AstraZeneca’s COVID-19 vaccine have pointed to the potential for AZD1222 to work after a single dose and limit asymptomatic cases; however, missed main questions regarding the efficacy of the candidate. The results that were posted in The Lancet restate the headline findings shared by AstraZeneca and its partners at the University of Oxford. In a pooled analysis of 11,636 participants enrolled in two separate clinical trials in the U.K. and Brazil, the efficacy of two doses of the vaccine was 70%. The paper includes the detail that protection against the symp...

Explore More...

Mucopolysaccharidosis

Mucopolysaccharidosis I (MPS I) (Hurler Syndrome) – a lesser developed window

Default Blog Image

GeneDx secures $92M funding; BioTech Innovations partners with Novartis for R&D collaboration

Parkinson

Snippets : Parkinson

NPC

Niemann-Pick disease type C (NPC) -A Rare Cognitive Decline Indication

endometriosis

Snippet : Endometriosis

Acute lymphoblastic leukemia

Snippet : Acute lymphoblastic leukemia

Therapeutics

Business Cocktail

astellas

Commercial Outcomes – Novartis

cancer

Key Clinical Outcomes- 30/07/2018

aristada

Neuroscience Highlights – 17/07/2018

MERCK ONCOLOGY

Oncology Highlights – 30/07/2018

acute myeloid leukemia

Predicting risk of Acute Myeloid Leukemia (AML) in healthy individuals

transthyretin amyloidosis

Notizia

allergic conjunctivitis

Allergic Conjunctivitis (AC)- Market Insights, Epidemiology and Market Forecast- 2027

Default Blog Image

Allergic Conjunctivitis (AC) – Common disorder with increasing prevalence

enzymes FAAH

Fatty Acid Amide Hydrolase (FAAH) Inhibitor – an enzyme with novel therapeutic potential

Subscribe to our Updates

DelveInsight is dedicated to safeguarding your data. We ensure that your information is handled in compliance with relevant data privacy legislation, our internal guidelines, and our privacy policy.

Receive recent Healthcare updates directly in your inbox.

Daily

Weekly

Monthly